Another study demonstrated that increased sLOX‐1 levels made the patients with acute coronary syndrome more vulnerable to disease recurrence and death (Kume, Mitsuoka, Hayashida, Tanaka, & Kita, 2010). This evidence concerns the gene OLR1 and acute coronary syndrome.